MEDIUM confidence: 100% data completeness, but the composite (39) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $97 avg across 5 analysts.
Buy-rated share 38% → 40% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $1.83 | $2.01 | +9.8% |
| May 2026 | $-0.10 | $-0.77 | -708.4% |
| Feb 2026 | $-1.47 | $-0.25 | +83.0% |
| Oct 2025 | $0.18 | $-0.29 | -261.1% |
| Aug 2025 | $0.06 | $-0.09 | -250.0% |
| May 2025 | $0.70 | $-0.31 | -144.3% |
| Feb 2025 | $1.05 | $0.06 | -94.3% |
| Nov 2024 | $2.21 | $1.41 | -36.2% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $11.8B— | $15.8B+34.1% | $12.5B-20.6% | $12.1B-3.2% | $11.2B-8.0% |
| EPS (dil.) | $15.58— | $17.35+11.4% | $3.70-78.7% | $4.64+25.4% | $-11.73-352.8% |
| Free Cash Flow | $1.7B— | $2.3B+31.7% | $1.3B-43.1% | $306M-76.5% | -$530M-273.2% |
| Gross Margin | 29.7% | 25.8%-3.9pp | 17.7%-8.1pp | 16.1%-1.6pp | 2.6%-13.5pp |
| Operating Margin | 23.8% | 19.3%-4.5pp | 5.8%-13.5pp | 7.2%+1.4pp | -14.1%-21.3pp |
| Net Margin | 17.1% | 14.2%-2.9pp | 3.8%-10.4pp | 5.0%+1.1pp | -13.5%-18.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$7.2M over 180 days (0 open-market buys, 6 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 0.9%/yr (revenue basis).
Base free cash flow $359M (avg FY2023–FY2025; latest year -$530M) · equity value $10.2B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 39 for Westlake Corporation indicates a relatively weak investment profile, driven down by low scores in Growth and Profitability, with the latter exhibiting a negative ROE of -13.9% and operating margin of -10.9%. The stock's Value score is also low, with a P/B of 1.2, while its Momentum score is slightly higher at 43, reflecting a 12-month return of -6.5% and a bearish 50-day versus 200-day moving average trend. The long-term and short-term scores diverge by 6 points, with the short-term score being slightly higher at 42.